Blocking IL-17A promotes the resolution of pulmonary inflammation and fibrosis via TGF-β1-dependent and -independent mechanisms

Journal of Immunology

Volumn 187, Issue 6, 2011, Pages 3003-3014

  Mi, Su ^a   Li, Zhe ^a   Yang, Hong Zhen ^a   Liu, Hong ^a   Wang, Jia Ping ^a   Ma, Yong Gang ^a   Wang, Xiao Xing ^a   Liu, Han Zhi ^a   Sun, Wei ^a   Hu, Zhuo Wei ^a  

^a INSTITUTE OF MATERIA MEDICA   (China)

Author keywords

[No Author keywords available]

Indexed keywords

3 METHYLAMPHETAMINE; BLEOMYCIN; COLLAGEN; INTERLEUKIN 17; INTERLEUKIN 17 ANTIBODY; METHAMPHETAMINE; SILICON DIOXIDE; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOPHAGY; CELL DEATH; COLLAGEN DEGRADATION; COLLAGEN SYNTHESIS; CONTROLLED STUDY; EPITHELIAL MESENCHYMAL TRANSITION; IMMUNE RESPONSE; IN VIVO STUDY; LUNG ALVEOLUS EPITHELIUM; LUNG FIBROSIS; MALE; MOLECULAR MECHANICS; MOUSE; NONHUMAN; PNEUMONIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SECRETION; PROTEIN TARGETING; REGULATORY MECHANISM; RISK FACTOR; SIGNAL TRANSDUCTION; SURVIVAL RATE; TH1 CELL;

ANIMALS; AUTOPHAGY; BLOTTING, WESTERN; BRONCHOALVEOLAR LAVAGE FLUID; CELL SEPARATION; COLLAGEN; EPITHELIAL-MESENCHYMAL TRANSITION; FLOW CYTOMETRY; INTERLEUKIN-17; MALE; MICE; MICE, INBRED C57BL; MICROSCOPY, CONFOCAL; PNEUMONIA; PULMONARY FIBROSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TRANSFORMING GROWTH FACTOR BETA1;

EID: 80053070208     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1004081     Document Type: Article

References (38)

1. Wynn, T. A. 2008. Cellular and molecular mechanisms of fibrosis. J. Pathol. 214: 199-210. (Pubitemid 351160157)
2. Rieder, F., and C. Fiocchi. 2009. Intestinal fibrosis in IBD - a dynamic, multifactorial process. Nat. Rev. Gastroenterol. Hepatol. 6: 228-235.
3. Du Bois, R. M. 2010. Strategies for treating idiopathic pulmonary fibrosis. Nat. Rev. Drug Discov. 9: 129-140.
4. Pellman, J., R. C. Lyon, and F. Sheikh. 2010. Extracellular matrix remodeling in atrial fibrosis: mechanisms and implications in atrial fibrillation. J. Mol. Cell. Cardiol. 48: 461-467.
5. Swartz, R. D. 2009. Idiopathic retroperitoneal fibrosis: a review of the pathogenesis and approaches to treatment. Am. J. Kidney Dis. 54: 546-553.
6. Wynn, T. A. 2005. T(H)-17: a giant step from T(H)1 and T(H)2. Nat. Immunol. 6: 1069-1070.
7. Nathan, C., and A. Ding. 2010. Nonresolving inflammation. Cell 140: 871-882.
8. Park, H., Z. Li, X. O. Yang, S. H. Chang, R. Nurieva, Y. H. Wang, Y. Wang, L. Hood, Z. Zhu, Q. Tian, and C. Dong. 2005. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat. Immunol. 6: 1133-1141. (Pubitemid 41541791)
9. Ivanov, S., and A. Lindén. 2009. Interleukin-17 as a drug target in human disease. Trends Pharmacol. Sci. 30: 95-103.
10. Yoshizaki, A., K. Yanaba, Y. Iwata, K. Komura, A. Ogawa, Y. Akiyama, E. Muroi, T. Hara, F. Ogawa, M. Takenaka, et al. 2010. Cell adhesion molecules regulate fibrotic process via Th1/Th2/Th17 cell balance in a bleomycin-induced scleroderma model. J. Immunol. 185: 2502-2515.
11. Baldeviano, G. C., J. G. Barin, M. V. Talor, S. Srinivasan, D. Bedja, D. Zheng, K. Gabrielson, Y. Iwakura, N. R. Rose, and D. Cihakova. 2010. Interleukin-17A is dispensable for myocarditis but essential for the progression to dilated cardiomyopathy. Circ. Res. 106: 1646-1655.
12. Smith, E., K. M. Prasad, M. Butcher, A. Dobrian, J. K. Kolls, K. Ley, and E. Galkina. 2010. Blockade of interleukin-17A results in reduced atherosclerosis in apolipoprotein E-deficient mice. Circulation 121: 1746-1755.
13. Wilson, M. S., S. K. Madala, T. R. Ramalingam, B. R. Gochuico, I. O. Rosas, A. W. Cheever, and T. A. Wynn. 2010. Bleomycin and IL-1beta-mediated pulmonary fibrosis is IL-17A dependent. J. Exp. Med. 207: 535-552.
14. Yang, H. Z., B. Cui, H. Z. Liu, S. Mi, J. Yan, H. M. Yan, F. Hua, H. Lin, W. F. Cai, W. J. Xie, et al. 2009. Blocking TLR2 activity attenuates pulmonary metastases of tumor. PLoS ONE 4: e6520.
15. Yang, H. Z., B. Cui, H. Z. Liu, Z. R. Chen, H. M. Yan, F. Hua, and Z. W. Hu. 2009. Targeting TLR2 attenuates pulmonary inflammation and fibrosis by reversion of suppressive immune microenvironment. J. Immunol. 182: 692-702.
16. Knapp, S., S. Florquin, D. T. Golenbock, and T. Van der Poll. 2006. Pulmonary lipopolysaccharide (LPS)-binding protein inhibits the LPS-induced lung inflammation in vivo. J. Immunol. 176: 3189-3195.
17. Atabai, K., S. Jame, N. Azhar, A. Kuo, M. Lam, W. McKleroy, G. Dehart, S. Rahman, D. D. Xia, A. C. Melton, et al. 2009. Mfge8 diminishes the severity of tissue fibrosis in mice by binding and targeting collagen for uptake by macrophages. J. Clin. Invest. 119: 3713-3722.
18. Salazar, M., A. Carracedo, I. J. Salanueva, S. Hernández-Tiedra, M. Lorente, A. Egia, P. Vázquez, C. Blázquez, S. Torres, S. Garc?́a, et al. 2009. Cannabinoid action induces autophagy-mediated cell death through stimulation of ER stress in human glioma cells. J. Clin. Invest. 119: 1359-1372.
19. Hamacher-Brady, A., N. R. Brady, S. E. Logue, M. R. Sayen, M. Jinno, L. A. Kirshenbaum, R. A. Gottlieb, and A. B. Gustafsson. 2007. Response to myocardial ischemia/reperfusion injury involves Bnip3 and autophagy. Cell Death Differ. 14: 146-157. (Pubitemid 44911902)
20. Thiery, J. P., H. Acloque, R. Y. Huang, and M. A. Nieto. 2009. Epithelial-mesenchymal transitions in development and disease. Cell 139: 871-890.
21. Weaver, C. T., R. D. Hatton, P. R. Mangan, and L. E. Harrington. 2007. IL-17 family cytokines and the expanding diversity of effector T cell lineages. Annu. Rev. Immunol. 25: 821-852. (Pubitemid 46697925)
22. Xu, J., S. Lamouille, and R. Derynck. 2009. TGF-beta-induced epithelial to mesenchymal transition. Cell Res. 19: 156-172.
23. Leppkes, M., C. Becker, I. I. Ivanov, S. Hirth, S. Wirtz, C. Neufert, S. Pouly, A. J. Murphy, D. M. Valenzuela, G. D. Yancopoulos, et al. 2009. RORgamma-expressing Th17 cells induce murine chronic intestinal inflammation via redundant effects of IL-17A and IL-17F. Gastroenterology 136: 257-267.
24. Zitvogel, L., O. Kepp, and G. Kroemer. 2010. Decoding cell death signals in inflammation and immunity. Cell 140: 798-804.
25. Mizushima, N., T. Yoshimori, and B. Levine. 2010. Methods in mammalian autophagy research. Cell 140: 313-326.
26. Funderburk, S. F., Q. J. Wang, and Z. Yue. 2010. The Beclin 1-VPS34 complex - at the crossroads of autophagy and beyond. Trends Cell Biol. 20: 355-362.
27. Mathew, R., C. M. Karp, B. Beaudoin, N. Vuong, G. Chen, H. Y. Chen, K. Bray, A. Reddy, G. Bhanot, C. Gelinas, et al. 2009. Autophagy suppresses tumorigenesis through elimination of p62. Cell 137: 1062-1075.
28. Kroemer, G., and B. Levine. 2008. Autophagic cell death: the story of a misnomer. Nat. Rev. Mol. Cell Biol. 9: 1004-1010.
29. Furuta, N., T. Yoshimori, and A. Amano. 2010. Mediatory molecules that fuse autophagosomes and lysosomes. Autophagy 6: 417-418.
30. Aitken, K. J., C. Tolg, T. Panchal, B. Leslie, J. Yu, M. Elkelini, N. Sabha, D. J. Tse, A. J. Lorenzo, M. Hassouna, and D. J. Bägli. 2010. Mammalian target of rapamycin (mTOR) induces proliferation and de-differentiation responses to three coordinate pathophysiologic stimuli (mechanical strain, hypoxia, and extracellular matrix remodeling) in rat bladder smooth muscle. Am. J. Pathol. 176: 304-319.
31. Liu, Y. Y., W. F. Cai, H. Z. Yang, B. Cui, Z. R. Chen, H. Z. Liu, J. Yan, W. Jin, H. M. Yan, B. M. Xin, et al. 2008. Bacillus Calmette-Guérin and TLR4 agonist prevent cardiovascular hypertrophy and fibrosis by regulating immune microenvironment. J. Immunol. 180: 7349-7357.
32. Harris, J., S. A. De Haro, S. S. Master, J. Keane, E. A. Roberts, M. Delgado, and V. Deretic. 2007. T helper 2 cytokines inhibit autophagic control of intracellular Mycobacterium tuberculosis. Immunity 27: 505-517. (Pubitemid 47418681)
33. Mehal, W. Z., J. Iredale, and S. L. Friedman. 2011. Scraping fibrosis: expressway to the core of fibrosis. Nat. Med. 17: 552-553.
34. Kiyono, K., H. I. Suzuki, H. Matsuyama, Y. Morishita, A. Komuro, M. R. Kano, K. Sugimoto, and K. Miyazono. 2009. Autophagy is activated by TGF-beta and potentiates TGF-beta-mediated growth inhibition in human hepatocellular carcinoma cells. Cancer Res. 69: 8844-8852.
35. Koesters, R., B. Kaissling, M. Lehir, N. Picard, F. Theilig, R. Gebhardt, A. B. Glick, B. Hähnel, H. Hosser, H. J. Gröne, and W. Kriz. 2010. Tubular overexpression of transforming growth factor-beta1 induces autophagy and fibrosis but not mesenchymal transition of renal epithelial cells. Am. J. Pathol. 177: 632-643.
36. Buckley, S., C. Medina, and C. Ehrhardt. 2009. Characterisation of the role of inflammatory cytokines in EMT and cell migration in alveolar epithelial cells. Am. J. Respir. Crit. Care Med. 179: A5298.
37. Li, L., L. Huang, A. L. Vergis, H. Ye, A. Bajwa, V. Narayan, R. M. Strieter, D. L. Rosin, and M. D. Okusa. 2010. IL-17 produced by neutrophils regulates IFN-gamma-mediated neutrophil migration in mouse kidney ischemiareperfusion injury. J. Clin. Invest. 120: 331-342.
38. Doodes, P. D., Y. Cao, K. M. Hamel, Y. Wang, R. L. Rodeghero, K. Mikecz, T. T. Glant, Y. Iwakura, and A. Finnegan. 2010. IFN-gamma regulates the requirement for IL-17 in proteoglycan-induced arthritis. J. Immunol. 184: 1552-1559